Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03641482
Other study ID # 0002
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2016
Est. completion date February 20, 2018

Study information

Verified date March 2019
Source Universidad Complutense de Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Alveolar osteitis is one of the most frequent complications after lower third molar extraction, and is usually accompanied by inflammation, pain and poor wound healing. Several local interventions have been used to reduce these complications with limited effectiveness.

Purpose: To clinically evaluate the use of propolis extract, nanovitamin C and nanovitamin E gel for the prevention of surgical complications related to impacted lower third molar extraction.

Methods: A randomized, triple-blind, split-mouth, pilot study is being performed in patients needing bilateral lower third molar extraction with similar surgical difficulty. Surgical extractions are randomly being performed and NBF gingival gel (TG) or placebo (PBG) are randomly being applied inside postextraction sockets by a blinded surgeon. The patients are being instructed to apply it 3 times/day in the surgical wound for 7 days. One month later, the contralateral wisdom tooth is being extracted and the opposite gel is being applied. Alveolar osteitis (AO) is being diagnosed following Blum's criteria. Swelling is being assessed by measuring the facial perimeter. Wound healing is being evaluated with a semi-quantitative scale as good, satisfactory or insufficient. Postoperative pain is being recorded using a visual analog scale (VAS) for 7 days. Analgesic pill intake is being recorded by each patient. Variables are being registered by a blinded researcher to 3M extractions at one, two, three and seven postoperative days.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date February 20, 2018
Est. primary completion date July 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

The inclusion criteria are:

- cooperative adult patients able to fulfil the study protocol,

- needing surgical extractions of both lower third molars,

- with similar surgical difficulty according to Pederson scale.

Exclusion Criteria:

The exclusion criteria are

- refuse to participate in the study,

- failure to attend 24, 48, and 72 hours, as well as, 7 days post-surgical appointment visits,

- smokers,

- systemic diseases as diabetes mellitus or being immunosuppressed,

- patients who take local or systemic antibiotics less than 3 months ago, anti-inflammatory or anticoagulant medication in the previous 4 weeks,

- patients who require antibiotic prophylaxis,

- pregnant or breastfeeding women,

- patients with chronic periodontitis in active phase or

- with history of allergies to any of the components of local anaesthetics, antibiotics, AINEs, or NBF gingival gel.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
NBF
Once the molar is extracted, the socket is cleaned with water, NBF gel is introduced, and the flap is closed. Then, the patients are instructed to apply NBF Gel in the surgical wound 3 times per day for 7 days after brushing their teeth. Previously they have to dry the area of the wound with gauze.
Device:
Placebo
Once the molar is extracted, the socket is cleaned with water, placebo gel is introduced, and the flap is closed. Then, the patients are instructed to apply placebo gel in the surgical wound 3 times per day for 7 days after brushing their teeth. Previously they have to dry the area of the wound with gauze.

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Universidad Complutense de Madrid Bio Nature Essences S.L

References & Publications (3)

Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg. 2002 Jun;31(3):309-17. Review. — View Citation

Haraji A, Rakhshan V, Khamverdi N, Alishahi HK. Effects of intra-alveolar placement of 0.2% chlorhexidine bioadhesive gel on dry socket incidence and postsurgical pain: a double-blind split-mouth randomized controlled clinical trial. J Orofac Pain. 2013 Summer;27(3):256-62. doi: 10.11607/jop.1142. — View Citation

Madrazo-Jiménez M, Rodríguez-Caballero Á, Serrera-Figallo MÁ, Garrido-Serrano R, Gutiérrez-Corrales A, Gutiérrez-Pérez JL, Torres-Lagares D. The effects of a topical gel containing chitosan, 0,2% chlorhexidine, allantoin and despanthenol on the wound healing process subsequent to impacted lower third molar extraction. Med Oral Patol Oral Cir Bucal. 2016 Nov 1;21(6):e696-e702. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Alveolar Osteitis: intense neuralgic pain in the post-extraction socket in the second or third postoperative day that do not disappear with analgesics beside a partially or totally disintegrated clot yes or no from baseline to 24, 48, 72 hours post intervention
Secondary Swelling: it was evaluated with a flexible metric tape measuring the facial perimeter from trago to pogonion. A first measurement was made before surgery, which was compared with the measurements taken at 24, 48 and 72 hours of the extraction. changes from baseline to 24, 48, 72 hours and 7 days post intervention
Secondary Trismus: it was assessed measuring the maximum opening from the inter incisive points. changes from baseline to 24, 48, 72 hours and 7 days post intervention
Secondary Wound healing: it was assessed with a semi-quantitative scale (good, satisfactory or insufficient). changes from baseline to 1 week post intervention
Secondary Post extraction pain: it was recorded using a visual analog scale, ranging from 0 (no pain) to 10 (the worst pain imaginable) at 9 pm of 7 consecutive days. changes from baseline to 1 week post intervention
Secondary Number of rescue analgesic pills consumption: recorded for the first 3 days by the patients. number from baseline to 3 days post intervention
See also
  Status Clinical Trial Phase
Completed NCT04091399 - First-in-man Study of Adult Patients Suffered From Alveolar Osteitis Treated Using Stomatological Tamponade Contipro Phase 2
Recruiting NCT05615272 - Treatment of Alveolar Osteitis: Traditional or Regenerative? N/A
Active, not recruiting NCT06435832 - Evaluations of the Effects of Tranexamic Acid and Chlorhexidine Gel on Alveolar Osteitis Incidence N/A
Not yet recruiting NCT05850650 - The Effect of Post-extraction Collagen Sponge Application on Alveolar Osteitis Phase 2
Recruiting NCT04853589 - Effect of Hyaluronic Acid on the Therapy of Alveolar Osteitis N/A
Completed NCT02382809 - Efficacy of 0.2 % Digluconate Chlorhexidine Mouthwash for Preventing Alveolar Osteitis After Third Molar Extraction Phase 4
Completed NCT00118820 - Antibiotic Efficacy in Third Molar Surgery Phase 3
Completed NCT04151147 - Effect of CGF on Frequency of Alveolar Osteitis Following Partially Erupted Mandibular Third Molar Surgery N/A
Enrolling by invitation NCT04476121 - Use of PRF in Treatment of Dry Socket. N/A
Completed NCT04507009 - Clinical Investigation of the Efficacy of CGF and Ozone in the Treatment of Alveolar Osteitis N/A